Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, to deliver precise, programable single-course therapeutics while preserving genomic integrity.
Founded by the world’s foremost experts in genomic medicine and backed by industry-leading investors, Chroma is working at the cutting edge of precision genetic medicine, building an entirely new class of therapeutics that can precisely and durably control gene expression without changing or cutting the underlying DNA sequence. Chroma is rapidly advancing novel epigenetic editing therapeutics to patients who are living with serious diseases.
We are hiring at our Boston, Massachusetts site, offering a unique opportunity to be part of our foundational Chroma team.
The Vice President, Clinical Operations leads the Clinical Operations capability, providing strategic input, guiding infrastructure development, and delivering on the execution of clinical trials at Chroma. We are moving rapidly toward the first clinical trials of our epigenetic editors and this role will be responsible for building and leading our clinical operations function to support successful trials. The Vice President, Clinical Operations will demonstrate a robust blend of leadership, operational expertise, vendor management, and cross-functional collaboration.
Chroma Medicine is an equal opportunity employer, providing equal opportunities to all employees and applicants for employment without regard to race, color, religion, sex or gender identity, national origin, age, disability, sexual orientation or genetics. In addition to federal law requirements, Chroma Medicine complies with applicable state and local laws governing nondiscrimination in employment.
COVID-19 Vaccination Policy: All Chroma Medicine team members must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemptions for medical or sincerely held religious beliefs will be considered.